Skip to main content
Top
Published in: Drug Safety 4/2015

01-04-2015 | Current Opinion

Empowering Consumers as Contributors for Health Product Safety: Lessons from the Philippines

Author: Kenneth Hartigan-Go

Published in: Drug Safety | Issue 4/2015

Login to get access

Abstract

Empowering consumers to contribute to adverse drug reaction reporting seems a sensible innovation, particularly when traditional reports emanating from healthcare professionals are neither increasing nor improving. This work, inspired by an EU-FP7-funded project, describes an attempt by the Philippines to introduce a consumer reporting system through education and an online platform for reporting, and the lessons that were captured in the process. While participating consumers did not contribute to the adverse drug reporting process in the traditional sense as originally expected, the reports received by the drug regulatory agency revealed consumers’ concerns regarding health product legitimacy, quality and market claims, as well as the lack of available and accessible information. These reports led regulators to take action. Initial insights on consumer behavior are proposed for regulators and industry to consider in greater depth and how this may impact on consumers providing valued information that will promote other aspects of product safety.
Literature
3.
go back to reference Christensen CM, Grossman JH, Hwang J. Integrating to make it happen. In: Christensen CM, Grossman JH, Hwang J, editors. The innovator’s prescription: a disruptive solution for health care. New York: McGraw-Hill; 2009. p. 183–220. Christensen CM, Grossman JH, Hwang J. Integrating to make it happen. In: Christensen CM, Grossman JH, Hwang J, editors. The innovator’s prescription: a disruptive solution for health care. New York: McGraw-Hill; 2009. p. 183–220.
4.
go back to reference Hartigan-Go K. Challenges of drug risk communications in the Philippines. Drug Saf. 2012;35(11):995–1004.PubMed Hartigan-Go K. Challenges of drug risk communications in the Philippines. Drug Saf. 2012;35(11):995–1004.PubMed
5.
go back to reference Van Hunsel F, Harmark L, Pal S, Olsson S, Van Grootheest K. Experiences with adverse drug reaction reporting by patients. Drug Saf. 2012;35(1):45–60.CrossRefPubMed Van Hunsel F, Harmark L, Pal S, Olsson S, Van Grootheest K. Experiences with adverse drug reaction reporting by patients. Drug Saf. 2012;35(1):45–60.CrossRefPubMed
6.
go back to reference Hsiao W, Reich MR, Takemi T. Regulations. In: Roberts MJ, Hsiao W, Berman P, Reich MR, editors. Getting health reform right: a guide to improving performance and equity. Oxford: Oxford University Press; 2003. p. 247–80. Hsiao W, Reich MR, Takemi T. Regulations. In: Roberts MJ, Hsiao W, Berman P, Reich MR, editors. Getting health reform right: a guide to improving performance and equity. Oxford: Oxford University Press; 2003. p. 247–80.
7.
go back to reference Bennis W, Goleman D, Biederman PW. Creating a culture of candor. In: Bennis W, Goleman D, O’Toole J, editors. Transparency: how leaders create a culture of candor. San Francisco (CA): Jossey-Bass; 2008. p. 1–43. Bennis W, Goleman D, Biederman PW. Creating a culture of candor. In: Bennis W, Goleman D, O’Toole J, editors. Transparency: how leaders create a culture of candor. San Francisco (CA): Jossey-Bass; 2008. p. 1–43.
12.
go back to reference Hopkins DM, Kontnik LT, Turnage MT. Pharmaceuticals. In: Hopkins DM, Kontnik LT, Turnage MT, editors. Counterfeiting exposed. Hoboken (NJ): Wiley; 2003. p. 69–93. Hopkins DM, Kontnik LT, Turnage MT. Pharmaceuticals. In: Hopkins DM, Kontnik LT, Turnage MT, editors. Counterfeiting exposed. Hoboken (NJ): Wiley; 2003. p. 69–93.
13.
go back to reference McAdams T, Neslund N, Zucker KD. Business, torts and product liability. In: McAdams T, Neslund N, Zucker KD, editors. Law, business and society. 10th ed. New York: McGraw-Hill; 2012. p. 282–330. McAdams T, Neslund N, Zucker KD. Business, torts and product liability. In: McAdams T, Neslund N, Zucker KD, editors. Law, business and society. 10th ed. New York: McGraw-Hill; 2012. p. 282–330.
14.
go back to reference Rifkin E, Bouwer E. The physician’s and patient’s perspectives. In: Rifkin E, Bouwer E, editors. The illusion of certainty (health benefits and risks). Berlin: Springer; 2007. p. 167–87.CrossRef Rifkin E, Bouwer E. The physician’s and patient’s perspectives. In: Rifkin E, Bouwer E, editors. The illusion of certainty (health benefits and risks). Berlin: Springer; 2007. p. 167–87.CrossRef
15.
go back to reference Frank RG. Behavioral economics and health economics. In: Diamond P, Vartiainen H, editors. Behavioral economics and its applications. Princeton: Princeton University Press; 2007. p. 195–234. Frank RG. Behavioral economics and health economics. In: Diamond P, Vartiainen H, editors. Behavioral economics and its applications. Princeton: Princeton University Press; 2007. p. 195–234.
16.
go back to reference Mowen JC, Minor M. Information processing I: involvement and perception. In: Mowen JC, Minor M, editors. Consumer behavior. 5th ed. USA: Prentice Hall; 2000. p. 64–6. Mowen JC, Minor M. Information processing I: involvement and perception. In: Mowen JC, Minor M, editors. Consumer behavior. 5th ed. USA: Prentice Hall; 2000. p. 64–6.
17.
go back to reference Van Hunsel F, ten Berge E, Borgsteede SD, et al. What motivates patients to report ADR? Ann Pharmacother. 2010;44:936–7.CrossRefPubMed Van Hunsel F, ten Berge E, Borgsteede SD, et al. What motivates patients to report ADR? Ann Pharmacother. 2010;44:936–7.CrossRefPubMed
18.
go back to reference East R, Wright M, Vanhuele M. Consumer behaviour: applications in marketing. Thousand Oaks (CA): Sage Publishing; 2008. p. 166–90. East R, Wright M, Vanhuele M. Consumer behaviour: applications in marketing. Thousand Oaks (CA): Sage Publishing; 2008. p. 166–90.
21.
go back to reference Van Hunsel F, van Puijenbroek E, de Jong-van den Berg LTW, et al. Media attention and influence on reporting odds ratio in disproportionality analysis: an example of patient reporting of statins. Pharmacoepidemiol Drug Saf. 2010;19:26–32.CrossRefPubMed Van Hunsel F, van Puijenbroek E, de Jong-van den Berg LTW, et al. Media attention and influence on reporting odds ratio in disproportionality analysis: an example of patient reporting of statins. Pharmacoepidemiol Drug Saf. 2010;19:26–32.CrossRefPubMed
22.
go back to reference Kotler P, Roberto EL. The nature and role of social campaigns to change public behavior. In: Social marketing. New York: Free Press, Macmillan Inc.; 1989. p. 3–23. Kotler P, Roberto EL. The nature and role of social campaigns to change public behavior. In: Social marketing. New York: Free Press, Macmillan Inc.; 1989. p. 3–23.
23.
go back to reference De Savigny D, Adam T, editors. Systems thinking for health systems strengthening. World Health Organization; 2009. p. 32. De Savigny D, Adam T, editors. Systems thinking for health systems strengthening. World Health Organization; 2009. p. 32.
24.
go back to reference Goldfarb A, Ho TH, Amaldoss W, et al. Behavioral models of managerial decision-making. Mark Lett. 2012;23:405–21.CrossRef Goldfarb A, Ho TH, Amaldoss W, et al. Behavioral models of managerial decision-making. Mark Lett. 2012;23:405–21.CrossRef
Metadata
Title
Empowering Consumers as Contributors for Health Product Safety: Lessons from the Philippines
Author
Kenneth Hartigan-Go
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 4/2015
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-015-0274-z

Other articles of this Issue 4/2015

Drug Safety 4/2015 Go to the issue